Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.
Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia; Department of Anatomy and Neuroscience, University of Melbourne, Parkville, Victoria, Australia.
Neurobiol Dis. 2020 Feb;134:104621. doi: 10.1016/j.nbd.2019.104621. Epub 2019 Oct 16.
The last decade has witnessed an exponentially growing interest in gut microbiota and the gut-brain axis in health and disease. Accumulating evidence from preclinical and clinical research indicate that gut microbiota, and their associated microbiomes, may influence pathogenic processes and thus the onset and progression of various diseases, including neurological and psychiatric disorders. In fact, gut dysbiosis (microbiota dysregulation) has been associated with a range of neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's and motor neuron disease, as well as multiple sclerosis. The gut microbiota constitutes a dynamic microbial system constantly challenged by many biological variables, including environmental factors. Since the gut microbiota constitute a changeable and experience-dependent ecosystem, they provide potential therapeutic targets that can be modulated as new interventions for dysbiosis-related disorders, including neurodegenerative diseases. This article reviews the evidence for environmental modulation of gut microbiota and its relevance to brain disorders, exploring in particular the implications for neurodegenerative diseases. We will focus on three major environmental factors that are known to influence the onset and progression of those diseases, namely exercise, diet and stress. Further exploration of environmental modulation, acting via both peripheral (e.g. gut microbiota and associated metabolic dysfunction or 'metabolopathy') and central (e.g. direct effects on CNS neurons and glia) mechanisms, may lead to the development of novel therapeutic approaches, such as enviromimetics, for a wide range of neurological and psychiatric disorders.
过去十年,人们对肠道微生物群和肠道-大脑轴在健康和疾病中的作用产生了浓厚的兴趣。越来越多的临床前和临床研究证据表明,肠道微生物群及其相关的微生物组可能影响致病过程,从而影响各种疾病的发生和发展,包括神经和精神疾病。事实上,肠道菌群失调(微生物组失调)与一系列神经退行性疾病有关,包括阿尔茨海默病、帕金森病、亨廷顿病和运动神经元病,以及多发性硬化症。肠道微生物群构成了一个动态的微生物系统,不断受到许多生物变量的挑战,包括环境因素。由于肠道微生物群构成了一个可变的、依赖经验的生态系统,它们提供了潜在的治疗靶点,可以作为治疗与菌群失调相关疾病的新干预措施进行调节,包括神经退行性疾病。本文综述了环境对肠道微生物群的调节及其与大脑疾病的相关性的证据,特别是探讨了其对神经退行性疾病的影响。我们将重点关注三个已知会影响这些疾病发生和发展的主要环境因素,即运动、饮食和压力。进一步探索环境调节作用,通过外周(例如肠道微生物群和相关的代谢功能障碍或“代谢病”)和中枢(例如对中枢神经系统神经元和神经胶质的直接影响)机制,可能会为各种神经和精神疾病开发新的治疗方法,例如环境模拟疗法。